Dimethyl Sulfoxide
Apexbio Technology LLC Lopinavir 192725-17-0 10mM (in 1mL DMSO)
Lopinavir is an inhibitor targeting the human immunodeficiency virus (HIV) protease enzyme implicated in viral polyprotein cleavage and maturation Structurally analogous to ritonavir lopinavir binds to HIV protease and suppresses catalytic activity consequently blocking HIV replication It demonstrates potent inhibitory actions against both wild-type and protease-inhibitor-resistant HIV variants Reported inhibition constants (Ki) for lopinavir range between 1 3 and 3 6 pM with antiviral efficacy represented by an EC50 below 0 06 M against protease mutants such as Val82 variants Due to its low susceptibility to inhibition by human serum proteins lopinavir is frequently utilized in antiviral screening assays drug-resistance research and investigations into HIV enzymology and resistance mechanisms
Apexbio Technology LLC RepSox 446859-33-2 10mM (in 1mL DMSO)
RepSox (CAS 446859-33-2) is a selective small-molecule inhibitor of TGF receptor-1 (TGF R-1) a serine/threonine kinase receptor involved in regulating tumor transformation cell proliferation and differentiation via TGF signaling pathways RepSox inhibits TGF R-1 activity with an IC50 of 23 nM thereby modulating downstream signaling events In cellular studies RepSox facilitated reprogramming of mouse embryonic fibroblasts (MEFs) into induced pluripotent stem cells (iPSCs) by functionally substituting for Sox2 Due to its capacity to significantly alter expression profiles linked to TGF signaling RepSox serves as a useful tool in stem cell research and cellular reprogramming studies
Apexbio Technology LLC Edaravone 89-25-8 10mM (in 1mL DMSO)
Edaravone (CAS 89-25-8) is a small-molecule antioxidant and free radical scavenger that mitigates cell injury primarily by intercepting reactive oxygen species and suppressing oxidative stress responses Its cytoprotective mechanism has been linked to the inhibition of lipid peroxidation pathways potentially involving suppression of lipoxygenase activity Edaravone has been investigated for neuroprotective effects notably demonstrating protection against neurotoxicity induced by MPTP a well-established model to study Parkinson s disease pathology This compound serves as a significant research tool for examining oxidative injury in ischemic and neurodegenerative conditions
Apexbio Technology LLC Raltegravir (MK-0518) 518048-05-0 10mM (in 1mL DMSO)
Raltegravir (MK-0518) is an inhibitor targeting HIV-1 integrase an enzyme essential for viral genome integration into host cellular DNA This compound disrupts the integrase-catalyzed strand transfer step during viral replication thereby hindering productive HIV infection In vitro studies demonstrate that Raltegravir inhibits replication of multidrug-resistant strains and isolates utilizing either CCR5 or CXCR4 coreceptors Its reported IC50 values typically range within the low nanomolar concentration levels Raltegravir is widely employed as a tool molecule in antiviral mechanism research drug resistance assays and preclinical HIV therapy-focused drug screening studies
Apexbio Technology LLC Triptolide 38748-32-2 10mM (in 1mL DMSO)
Triptolide (CAS 38748-32-2) is a biologically active diterpenoid originally isolated from the traditional Chinese herb Tripterygium wilfordii It exerts inhibitory effects by suppressing interleukin-2 expression in activated T cells and impeding NF- B-mediated transcriptional activation Triptolide inhibits invasion and migration of ovarian cancer cells via reducing matrix metalloproteinases MMP-7 and MMP-19 expression and enhancing E-cadherin expression Additionally it induces RNA polymerase II degradation leading to apoptosis and reduced proliferation in cancer cell lines and rheumatoid arthritis synovial fibroblasts Consequently triptolide serves as a valuable tool for immunology oncology and inflammation research
eMolecules n-Butyl sulfoxide | 2168-93-6 | MFCD00002093 | 25g
Oakwood Chemicals | n-Butyl sulfoxide | 25g | 480102057 | 002969 | | 2168-93-6 | MFCD00002093 | 162.290 | C8H18OS
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool
Sigma Aldrich Fine Chemicals Biosciences Dimethyl sulfoxide anhydrous, >=99.9% | 67-68-5 | MFCD00002089 | 2L
Dimethyl sulfoxide anhydrous, >=99.9% | Purity: >=99.9% | Mol Wt: 78.13 | 67-68-5 | MFCD00002089 | 2L
Sigma Aldrich Fine Chemicals Biosciences Promethazine sulfoxide Bri
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.for further information and support please go to the website of the issuing Pharmacopoeia.
Apexbio Technology LLC Doxercalciferol 54573-75-0 10mM (in 1mL DMSO)
Doxercalciferol chemically known as 1 -Hydroxyvitamin D2 is a synthetic analog of vitamin D2 characterized by selective activation of the vitamin D receptor (VDR) Upon metabolic activation Doxercalciferol undergoes hepatic transformation to its biologically active form inducing gene transcription mediated via the VDR signaling pathway Central to its mechanism activated VDR regulates calcium and phosphate homeostasis influencing cellular differentiation proliferation and parathyroid hormone expression In biomedical research Doxercalciferol serves as a tool compound to investigate the molecular pathways regulated by vitamin D receptor activation particularly in renal insufficiency models bone metabolism studies and parathyroid physiology experiments
Apexbio Technology LLC PP 2 (AG 1879) 172889-27-9 10mM (in 1mL DMSO)
PP 2 (AG 1879 CAS 172889-27-9) is a selective inhibitor targeting Src family tyrosine kinases such as Lck and Fyn with reported IC50 values of approximately 4 nM and 5 nM respectively Src family kinases are composed of nine closely related tyrosine kinases including Src Yes Fyn Fgr Yrk Lyn Blk Hck and Lck PP 2 suppresses early T-cell signaling by blocking Lck- and Fyn-mediated tyrosine phosphorylation following anti-CD3 stimulation Research in glioma cell models (U251) has demonstrated PP 2-mediated inhibition of Src-dependent cellular invasion and proliferation at micromolar concentrations PP 2 exhibits moderate inhibitory activity toward EGF-R (IC50 480 nM) and minimal effect on ZAP-70 and JAK2 Thus PP 2 serves as a research tool for studying Src kinase-dependent signaling pathways implicated in cancer and immunological responses
Apexbio Technology LLC Golvatinib (E7050) 928037-13-2 10mM (in 1mL DMSO)
Golvatinib (E7050 CAS 928037-13-2) is a small-molecule inhibitor targeting the tyrosine kinases c-Met and VEGFR-2 Golvatinib inhibits phosphorylation of c-Met in MKN45 gastric cancer cells and VEGFR-2 in human umbilical vein endothelial cells (HUVECs) with IC50 values of 14 nM and 16 nM respectively Additionally it suppresses proliferation of various tumor cells including MKN45 EBC-1 Hs746T and SNU-5 and inhibits tumor growth in xenograft models via reduction of c-Met and VEGFR-2-mediated pathways Golvatinib is utilized in cancer research to explore targeted antitumor efficacy related to angiogenesis and oncogenic signaling
Apexbio Technology LLC CYT387 1056634-68-4 10mM (in 1mL DMSO)
CYT387 (CAS 1056634-68-4) is an aminopyrimidine derivative identified through high-throughput screening and optimized with structure-guided medicinal chemistry It functions as an inhibitor targeting Janus kinase family enzymes JAK1 JAK2 JAK3 and TYK2 with reported IC50 values of 11 nM 18 nM 155 nM and 17 nM respectively At concentrations between 500 1500 nM CYT387 selectively suppresses JAK2 signaling inhibits proliferation of JAK2-dependent hematopoietic cell lines and induces apoptosis with minimal effects on non-hematopoietic cells CYT387 is employed in experimental studies of JAK2-mediated signaling pathways and myeloproliferative neoplasms
Apexbio Technology LLC TAK-242 243984-11-4 10mM (in 1mL DMSO)
TAK-242 (CAS 243984-11-4) also known as resatorvid is a cyclohexene derivative that functions as a selective inhibitor of Toll-like receptor 4 (TLR4) signaling Mechanistically TAK-242 binds specifically to the intracellular domain of TLR4 disrupting its interaction with downstream adaptor proteins and thus suppressing activation of inflammatory signal pathways triggered by lipopolysaccharide (LPS) In vitro TAK-242 inhibits LPS-induced production of nitric oxide TNF- and interleukin-6 in macrophages (IC50 1 1 11 nM) Preclinical animal models indicate its potential usefulness in mitigating inflammatory responses associated with neuropsychiatric conditions triggered by stress
Apexbio Technology LLC Darapladib(Synonyms: SB-480848, Darapladib, LP-PLA2 inhibitor, SB480848), 10mM (in 1mL DMSO), CAS: A3349.
Darapladib (CAS 356057-34-6) is a selective inhibitor of lipoprotein-associated phospholipase A2 (Lp-PLA2) an enzyme strongly implicated in the progression and instability of atherosclerotic plaques In vitro Darapladib shows high potency toward Lp-PLA2 (IC50 approximately 270 pM) with minimal inhibition of other secretory PLA2 isoforms (e g III V X) Preclinical studies in ApoE-deficient mouse models demonstrate that inhibition of Lp-PLA2 attenuates vascular inflammatory processes and markedly reduces atherosclerotic lesion formation Clinically Darapladib administration in statin-treated patients significantly decreases plasma Lp-PLA2 activity and inflammatory markers indicating potential applications in cardiovascular research related to atherosclerosis and associated inflammation
Apexbio Technology LLC Raltitrexed 112887-68-0 10mM (in 1mL DMSO)
Raltitrexed (CAS 112887-68-0) also known as Tomudex or ZD 1694 is a small-molecule antimetabolite utilized primarily in oncology research As a thymidylate synthase inhibitor raltitrexed disrupts DNA synthesis by impeding nucleotide biosynthesis thereby exerting cytotoxic effects against rapidly dividing tumor cells The compound serves as a tool in cancer studies aimed at elucidating thymidylate synthase s role in tumor cell proliferation and evaluating antitumor therapeutic approaches targeting this enzymatic pathway